EUVIMED · CrossrefZeitschrift
Update on Cancer Therapeutics
ISSN 1872-115X · Elsevier BV
Neueste Artikel
Anti-CD40 agonist antibodies: Preclinical and clinical experience
Topoisomerase II inhibitors
Potential use of CpG ODN for cancer immunotherapy
Breast cancer
Multiple uses of tumor necrosis therapy (TNT) for the treatment and imaging of solid tumors: Preclinical considerations and progress
Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity
Update in the management of head and neck cancer
Neuroendocrine tumours
Bone sarcomas
Supportive care
AIDS associated malignancies
Molecular genetics and targeted therapies for cutaneous melanoma
Antibodies and antibody-fusion proteins as anti-angiogenic, anti-tumor agents
Cancer therapy with engineered monoclonal antibodies
Cancers of the bowel and hepatobiliary tract
Biology and therapy of solid tumors in childhood
Farnesyltransferase inhibitors
Lung cancer
Plasma cell dyscrasias and leukemias
Proteasome inhibitors and modulators of heat shock protein function
Tumor immune evasion mediated by IDO
Recent developments in the clinical activity of topoisomerase-1 inhibitors
New approaches to identification of antigenic candidates for future prostate cancer immunotherapy
Soft tissue sarcoma
Recent advances in the use of antigen-specific T cells for the treatment of cancer
Systemic therapy for gynecological neoplasms: Ovary, cervix and endometrium
Central nervous system tumors
Cyclin dependent kinases as targets for cancer therapy
Epidermal growth factor receptor pathway inhibitors
EUVIMED